Clinical trials
Attention Deficit Disorder with Hyperactivity trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen-Cilag International NV | 2 |
| Stéphanie Baggio | 2 |
| Definium Therapeutics US, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Kantonsspital Aarau | 1 |
| Luzerner Kantonsspital | 1 |
| Mensia Technologies SA | 1 |
| Nader Perroud | 1 |
| Onovis Augenpraxis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 18 |
| Brain Injuries, Traumatic | 1 |
| Multiple Sclerosis | 1 |
| Neurodevelopmental Disorders | 1 |
| Stroke | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.